A World Class Team Of Medical, Business And Finance Professionals

Our medical team has successfully disrupted opioid addition in over 3700 people.  We have been invited by Health Canada to apply for clinical trials.  We have operating clinics in other jurisdictions and intent to franchise our model globally.

We're in this for the long haul. It's a marathon not a sprint.

- Shayne Nyquvest
Chairman & Founder

Our Leadership Team

Dr. Jeremy Weate,
CEO

Jeremy has over 17 years strategic advisory experience, focused on minister-level guidance on the mining sector across over 50 projects in over 30 countries in Europe, Africa, Central Asia and the South Pacific. Jeremy also has a decade-long interest in the medicalization of ibogaine in a holistic treatment setting. He visited Gabon in 2016 and was initiated into Bwiti. In 2018, he helped set up Tabula Rasa Retreat in Portugal, now one of the leading ibogaine treatment facilities globally. He has organized ibogaine conferences in Vienna, Porto and London. He has a PhD in European philosophy from the University of Warwick, UK.

Greg Leavens,
CFO

Greg Leavens, CPA CA - a Calgary based financial executive (past CFO and Controller roles) with 30 years experience in public accounting and industry, including the oil & gas exploration / production and service sectors.  Greg started his career with KPMG, and has extensive experience in leadership, strategic planning, due diligence reviews, financing, forecasting, financial reporting, treasury and risk management, and regulatory compliance.  His background includes significant roles in planning, monitoring, and executing programs to aid in achieving high profitability, growth, and success of results oriented management teams, especially in start-up, entrepreneurial environments.

Richard Avis,
COO

Richard Avis is a senior management executive with a 30-year strong background in start-up management and franchising. He most recently operated a Vancouver-based advisory firm specializing in the growth & profitability of Startups, SMB’s, Emerging Brands and Franchised operations, including leadership mentoring, brand management, franchise compliance & marketing.

Our Board

Shayne Nyquvest,
Chairman & Founder

Shayne Nyquvest is the former Executive Vice President of Mackie Research Capital and a founding member of the Canaccord Genuity Group. Nyquvest can personally vouch for the transformational effects of ibogaine and aims to see this treatment adopted by the mainstream medical community as an answer to the opioid epidemic.

Chief Ian Campbell  

Chief Ian Campbell is a hereditary chief of the Squamish Nation located in Vancouver, British Columbia. He has served as an elected member of council since 2005, and was appointed as a Political Spokesperson in 2008. Since 1999 he has been the Cultural Ambassador and Negotiator for the Intergovernmental Relations Department of the Squamish Nation, advancing Aboriginal rights and title, while invigorating substantive economic opportunities through negotiations, collaboration, and partnerships.

Dr. Alberto Sola
MD, Co-Founder

Clear Sky Addiction Solution’s President, Dr Sola is a thought leader in entheogenic treatment. He has the distinction of having treated more patients with ibogaine than any other person in the world and is head of operations at Clear Sky Recovery. Dr. Sola graduated from Universidad Anahuac. As the Medical Director of Amerimed, he opened four emergency hospitals for tourists in Puerto Vallarta, Cancun, and Cabo San Lucas.

Dr. Jeremy Weate

Jeremy has over 17 years strategic advisory experience, focused on minister-level guidance on the mining sector across over 50 projects in over 30 countries in Europe, Africa, Central Asia and the South Pacific. Jeremy also has a decade-long interest in the medicalization of ibogaine in a holistic treatment setting. He visited Gabon in 2016 and was initiated into Bwiti. In 2018, he helped set up Tabula Rasa Retreat in Portugal, now of the leading ibogaine treatment facilities globally. He has organized ibogaine conferences in Vienna, Porto and London. He has a PhD in European philosophy from the University of Warwick, UK.

Robert Turner

Mr. Turner is President of his own incorporated consulting firm and a Principal within Western Management Consultants (WMC). His consulting focus is providing guidance to Boards on their governance including proper CEO oversight. Mr. Turner brings experience as a CHRO in both the private and public sectors. Subsequently, he joined Mercer Canada as a Partner focused on consulting within Canadian health care. Robert has served on Universal Ibogaine’s Advisory Board since December 2018. Robert has an ICD.D certification from Rotman Business School, an MBA from the Ivey Business School and a BSc (Biochemistry) from the University of Toronto. He serves on the Boards of two other corporations – one private and one not-for-profit.

Request Access to Investment Alerts!